Primary |
Urinary Tract Infection |
42.9% |
Depression |
14.3% |
Hypothyroidism |
14.3% |
Neuralgia |
14.3% |
Ph Urine |
14.3% |
|
Circulatory Collapse |
28.6% |
Intra-uterine Death |
28.6% |
Petechiae |
14.3% |
White Blood Cell Count Decreased |
14.3% |
Wrong Drug Administered |
14.3% |
|
Secondary |
Prophylaxis |
38.7% |
Acute Myeloid Leukaemia |
22.5% |
Multiple Myeloma |
9.9% |
Refractory Anaemia With An Excess Of Blasts |
4.2% |
Hiv Infection |
3.5% |
Drug Use For Unknown Indication |
2.8% |
Pain |
2.8% |
Acquired Immunodeficiency Syndrome |
2.1% |
Extravasation |
2.1% |
Myelodysplastic Syndrome |
2.1% |
Product Used For Unknown Indication |
2.1% |
Urinary Tract Infection |
2.1% |
Raynaud's Phenomenon |
1.4% |
Arthritis |
0.7% |
Chemotherapy |
0.7% |
Chronic Lymphocytic Leukaemia |
0.7% |
Dementia |
0.7% |
Suicide Attempt |
0.7% |
|
Nausea |
11.5% |
Leukopenia |
7.7% |
Pneumonia |
7.7% |
Tachycardia |
7.7% |
Thrombotic Thrombocytopenic Purpura |
7.7% |
Anuria |
3.8% |
Cardiomyopathy |
3.8% |
Dementia |
3.8% |
Drug Hypersensitivity |
3.8% |
Exfoliative Rash |
3.8% |
Hepatitis Acute |
3.8% |
Pneumonia Cytomegaloviral |
3.8% |
Rash |
3.8% |
Renal Failure Acute |
3.8% |
Sepsis |
3.8% |
Stem Cell Transplant |
3.8% |
Sudden Cardiac Death |
3.8% |
Supraventricular Tachycardia |
3.8% |
Transaminases Increased |
3.8% |
Urinary Tract Infection |
3.8% |
|
Concomitant |
Product Used For Unknown Indication |
18.0% |
Drug Use For Unknown Indication |
17.4% |
Hodgkin's Disease |
11.3% |
Multiple Myeloma |
8.2% |
Prophylaxis |
7.9% |
Hiv Infection |
4.8% |
Chronic Lymphocytic Leukaemia |
4.5% |
Infection Prophylaxis |
3.7% |
Pain |
3.3% |
B-cell Lymphoma |
2.8% |
Hypertension |
2.6% |
Diffuse Large B-cell Lymphoma |
2.5% |
Thrombosis Prophylaxis |
2.1% |
Renal Transplant |
1.9% |
Non-hodgkin's Lymphoma |
1.8% |
Mucosal Inflammation |
1.5% |
Premedication |
1.5% |
Acute Myeloid Leukaemia |
1.4% |
Liver Transplant |
1.4% |
Plasmacytoma |
1.4% |
|
Respiratory Failure |
9.2% |
White Blood Cell Count Decreased |
9.2% |
Sepsis |
7.9% |
Pyrexia |
6.6% |
Somnolence |
6.6% |
Malignant Melanoma In Situ |
5.3% |
Pneumonia |
5.3% |
Renal Failure Acute |
5.3% |
Supraventricular Tachycardia |
5.3% |
Bladder Cancer |
3.9% |
Cerebral Infarction |
3.9% |
Febrile Neutropenia |
3.9% |
General Physical Health Deterioration |
3.9% |
Haematopoietic Stem Cell Mobilisation |
3.9% |
Optic Atrophy |
3.9% |
Pancytopenia |
3.9% |
Vision Blurred |
3.9% |
Aggression |
2.6% |
Bradycardia |
2.6% |
Femur Fracture |
2.6% |
|